BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cardiovascular Disorder (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Scientists Claim Scrapped Roche Drug Could be First Personalized Heart Med     1/22/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine)     11/21/2014
Sanofi And Regeneron's Alirocumab Ph3 Trials Met Primary Efficacy Endpoint     11/20/2014
Merck & Co.'s Vytorin Proves Effective; IMPROVE-IT Trial Achieves Primary Endpoint     11/19/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
ZS Pharma Presents Positive Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia, At The American Heart Association Scientific Meeting And Announces Simultaneous Publication Of Results In JAMA     11/17/2014
Alnylam Pharmaceuticals Reports Positive Initial Phase 2 Data With Revusiran     11/14/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option     11/13/2014
AstraZeneca PLC To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta     11/13/2014
Cardiome Pharma Corp. Touts Positive Data From Phase 3 BRINAVESS® Trial     11/7/2014
FDA Panel Backs Daiichi Sankyo, Inc.'s New A-Fib Drug Savaysa     10/31/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France)     9/17/2014
Wall Street Overreacting To Amarin Denial: Citigroup Analyst     9/12/2014
Amgen, Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study     9/4/2014
 Featured Stories
Sitting Too Much? Even Exercise May Not Save You, University Health Network Study     1/21/2015
How Much Salt Should Older People Really Eat? Emory University Study     1/20/2015
Blueberries: Daily Cup May Reduce Blood Pressure, Florida State University Study     1/9/2015
An Avocado A Day Keeps Bad Cholesterol Away, Penn State University Study     1/9/2015
Hold Your Breath To Protect Your Heart, Thomas Jefferson University Study     1/7/2015
Eating Whole Grains Linked To A Longer Life, Harvard School of Public Health Study     1/6/2015
Only 4 In 10 Americans Eat Heart-Healthy Nuts Each Day, CDC Says     12/18/2014
Yoga May Guard Against Heart Disease, Erasmus MC Study Finds     12/17/2014
Obesity May Shorten Life Expectancy Up To 8 Years, McGill University Study     12/9/2014
Natural Substance In Red Wine Has An Anti-Inflammatory Effect In Cardiovascular Diseases, Johannes Gutenberg University Study     12/5/2014
Emotional Stress Affects Women's Heart More, Emory University Study     11/17/2014
Long Term Shift Work Linked To Impaired Brain Function, Occupational & Environmental Medicine Reveals     11/5/2014
Mental Health Disorders Double Heart Disease, Stroke Risk, Centre For Addiction And Mental Health Study     10/28/2014
Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study     10/21/2014
How Omega-6 Fatty Acids Lower Bad Cholesterol, Innsbruck Medical University Study     10/20/2014
 More News
American Heart Association Release: Daily Beet Juice Lowers Blood Pressure for High Blood Pressure Sufferers     1/21/2015
AstraZeneca PLC (AZN)'s Brilinta Boosted by Major Clinical Trial Success     1/14/2015
Auspex Pharmaceuticals (ASPX) Announces Favorable Topline Results From Thorough QT Clinical Trial Of SD-809     1/12/2015
MaRS Innovation Announces Collaboration With Johnson & Johnson (JNJ) Innovation And Janssen To Advance Cardiac, Diabetes And Depression Technologies     1/12/2015
Biostar Pharmaceuticals, Inc. (BSPM) Announces Signing Of Joint Research And Development Agreement With Northwest University For Further Development Of Danshensu Yibingzhi (IDHP), A Class One Drug For Treatment Of Cardiovascular Diseases     1/8/2015
Biocryst Pharmaceuticals (BCRX) Receives Orphan Drug Designation For BCX4161 For The Treatment Of Hereditary Angioedema     12/24/2014
New Published Data Show Pluristem Therapeutics (PSTI)'s PLX Cells Protect Neurons     12/22/2014
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF     12/19/2014
Additional Clinical Data From The Phase 2 Study With Ablynx (ABLYF)'s Anti-vWF Nanobody, Caplacizumab, Presented At The American Society of Hematology Annual Meeting     12/8/2014
Milestone Pharmaceuticals Announces Positive Phase 1 Data For MSP-2017; Supports Advancement Into Phase 2 In PSVT Patients     11/24/2014
Kaiser Permanente Release: Digoxin Associated With Higher Risk of Death and Hospitalization in Adults With Atrial Fibrillation and No Heart Failure     11/21/2014
NeoStem, Inc. Announces Initial Positive Data From Phase 2 Preserve AMI Clinical Trial     11/18/2014
Capricor Therapeutics, Inc. Announces Favorable ALLSTAR Phase I Safety Results     11/18/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Interim Data Reinforce Safety and Effectiveness of Pradaxa (dabigatran etexilate mesylate) versus Warfarin in Routine Care of Patients with Non-valvular Atrial Fibrillation     11/18/2014
CSL Release: CSL112 Found To Elevate Cholesterol Efflux In Patients With Coronary Artery Disease And Mechanism For Rapid Cholesterol Efflux Capacity Demonstrated     11/18/2014